Stockreport

Adagene to Participate in Investor Conferences in September

Adagene Inc. - ADS, each representing 1.25 ordinary shares  (ADAG) 
PDF SAN DIEGO and SUZHOU, China, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transfo [Read more]